drug · small molecule
linsitinib
Phase 3updated 3mo agoby Sling Therapeutics Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 9 investigational indications.
targets
Insulin receptorInsulin-like growth factor 1 receptor
all catalysts(0)
nothing on the calendar yet
Trials studying linsitinib
- phase3Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
- phase3Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
- phase3A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
- phase2A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that